Evidence map›Paper›PMID 36615475›Full record

ReviewMolecules (Basel, Switzerland)2022

Protective Effects of Ferulic Acid on Metabolic Syndrome: A Comprehensive Review.

Lei Ye, Pan Hu, Li-Ping Feng, Li-Lu Huang, Yi Wang, Xin Yan, Jing Xiong, Hou-Lin Xia

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 56 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Moro Orange (International journal of molecular sciences · 2025
    Article
  13. Review
  14. Review
  15. Nutritional composition ofOpen research Africa · 2025
    Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Lei YeSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Pan HuChengdu Institute of Chinese Herbal Medicine, Chengdu 610016, China.
Li-Ping FengSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Li-Lu HuangSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Yi WangSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Xin YanChengdu Institute of Chinese Herbal Medicine, Chengdu 610016, China.
Jing XiongChengdu Institute of Chinese Herbal Medicine, Chengdu 610016, China.
Hou-Lin XiaSchool of Pharmacy, Chengdu University of Traditional Chinese Medicine, Chengdu 611137, China.
Chengdu University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Metabolic syndrome (MetS) is a complex disease in which protein, fat, carbohydrates and other substances are metabolized in a disorderly way. Ferulic acid (FA) is a phenolic acid found in many vegetables, fruits, cereals and Chinese herbs that has a strong effect on ameliorating MetS. However, no review has summarized the mechanisms of FA in treating MetS. This review collected articles related to the effects of FA on ameliorating the common symptoms of MetS, such as diabetes, hyperlipidemia, hypertension and obesity, from different sources involving Web of Science, PubMed and Google Scholar, etc. This review summarizes the potential mechanisms of FA in improving various metabolic disorders according to the collected articles. FA ameliorates diabetes via the inhibition of the expressions of PEPCK, G6Pase and GP, the upregulation of the expressions of GK and GS, and the activation of the PI3K/Akt/GLUT4 signaling pathway. The decrease of blood pressure is related to the endothelial function of the aortas and RAAS. The improvement of the lipid spectrum is mediated via the suppression of the HMG-Co A reductase, by promoting the ACSL1 expression and by the regulation of the factors associated with lipid metabolism. Furthermore, FA inhibits obesity by upregulating the MEK/ERK pathway, the MAPK pathway and the AMPK signaling pathway and by inhibiting SREBP-1 expression. This review can be helpful for the development of FA as an appreciable agent for MetS treatment.

Indexed as

Metabolic DiseasesMetabolic SyndromeCoumaric AcidsHumansObesityPhosphatidylinositol 3-KinasesSignal TransductionCoumaric Acidsferulic acidPhosphatidylinositol 3-Kinasesdiabetesferulic acidhyperlipidemiahypertensionmetabolic syndromeobesity

Identifiers

PMID36615475
PMCPMC9821889
OpenAlexW4313294777

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.